Michaela Fleming

Melvin Weinstein, MD, discusses the current and emerging technologies for the laboratory diagnosis of bloodstream infections.

Los Angeles County Department of Public Health is investigating an influx of cases of flea-borne typhus in downtown Los Angeles.

Sarah Kemble, MD discusses trends identified from 33 point prevalence surveys that were performed across the Chicago area to identify colonization of Candida auris.

The CDC and USDA-FSIS are investigating an outbreak of Listeria monocytogenes infections linked to ready-to-eat deli ham products.

Roy Chemaly, MD, MPH discusses the findings of the phase 2 trial evaluating DAS181 for the treatment of parainfluenza virus lower respiratory tract infections in immunocompromised patients.

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, shares takeaways from her presentation on combination therapy for gram-negative agents at the 2018 SIDP Annual Meeting.

Kenneth Sherman, MD, discusses current trends in the treatment of hepatitis B in immunocompromised patients and highlights research exploring treatment options for patients coinfected with HIV.

Letermovir found to prevent clinically significant CMV infection in HCT patients with CMV DNA when compared to placebo in recent phase 3 trial.

A retrospective study evaluates ceftolozane/tazobactam in a large database of US hospitals to determine real-world patterns and outcomes associated with the treatment.

George Thompson, MD, principal investigator of the STRIVE study discusses optimal dosing for rezafungin in treating candidemia and/or invasive candidiasis.

Mary Choi, MD, MPH, discusses the progress made in treating and preventing Ebola and the challenges of fighting the community resistance of the Congolese.

The FDA has approved omadacycline (NUZYRA) as an intravenous and oral treatment option for adults with ABSSSI and CABP.

Despite current recommendations, Tdap vaccine coverage in pregnant women remains suboptimal.

While conducting passive surveillance of triazole-resistant Aspergillus fumigatus cases, the CDC observed some cases occurred in patients who had never taken the antifungal medication.

In September 2017, a patient in Hong Kong was diagnosed with rat hepatitis E virus after inflammation of the liver was observed.

In allogenic hematopoietic cell transplant patients, auto-FMT treatment led to the recovery of beneficial gut bacteria close to baseline levels within days.

Using an algorithm to determine course of treatment shortened antibiotic use by 2 days for patients with uncomplicated staphylococcal bacteremia infections.

The NIH has launched a phase 1 trial evaluating whether it is safe to administer infusions of 2 broadly neutralizing antibodies (bNAbs) in people living with HIV.

Hepatitis A outbreaks are active in 13 states across the United States, yet vaccination is required in only a fraction of them.

New research published in The BMJ indicates that the Pandemrix vaccine was linked with 5 times the number of adverse events reported from 2 other pandemic vaccines.

Global health officials are concerned about the potential consequences of the disruption to Ebola surveillance in the DRC outbreak caused by civil unrest.

A recent study by the Kirby Institute reported that after using direct-acting antiviral therapy 97% of participants with HCV who recently used injectable drugs achieved sustained viral response.

During the month of July, individuals in 4 states were found to have Shiga toxin-producing E coli O26 connected to contaminated ground beef consumption.

Investigators have discovered a genetic mutation that increases the burden of Aspergillus fumigatus and can lead to complications for patients with asthma.

During a multidrug-resistant Campylobacter outbreak, 142 puppies were identified as receiving 1 or more antibiotic courses before arriving or while at the store.

In August 2017, the FDA granted an NDA for a single-use of delamanid for a case of extensively drug-resistant tuberculosis.

The NIAID is sponsoring a phase 1 clinical trial to assess if a nasal influenza vaccine candidate used in combination with a licensed vaccine can enhance immune responses against influenza in children and teens.

The Ministry of Health and Child Care of Zimbabwe has declared a cholera outbreak after over 1,900 suspected cases have been reported.

Children’s Hospital Colorado reported an increase of pediatric cases of meningitis and encephalitis in which patients tested positive for enterovirus.

Investigators have developed an innovative method to identify molecules capable of eliminating the Leishmania parasite.